Boston Partners’s CDK Global, Inc. CDK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-187,918
Closed -$8M 722
2021
Q3
$8M Sell
187,918
-7,272
-4% -$328K 0.01% 372
2021
Q2
$9.7M Sell
195,190
-8,382
-4% -$444K 0.01% 363
2021
Q1
$11M Sell
203,572
-6,927
-3% -$359K 0.01% 361
2020
Q4
$10.9M Sell
210,499
-7,017
-3% -$333K 0.02% 336
2020
Q3
$9.48M Sell
217,516
-94,938
-30% -$4.22M 0.02% 340
2020
Q2
$12.9M Sell
312,454
-4,274,996
-93% -$165M 0.02% 320
2020
Q1
$151M Sell
4,587,450
-539,686
-11% -$25.8M 0.3% 102
2019
Q4
$280M Sell
5,127,136
-79,389
-2% -$4.08M 0.37% 84
2019
Q3
$250M Buy
5,206,525
+1,911,327
+58% +$91.5M 0.34% 96
2019
Q2
$163M Buy
3,295,198
+199,298
+6% +$10.7M 0.21% 143
2019
Q1
$182M Sell
3,095,900
-121,924
-4% -$6.65M 0.24% 130
2018
Q4
$154M Buy
3,217,824
+144,881
+5% +$7.64M 0.22% 131
2018
Q3
$192M Buy
3,072,943
+672,724
+28% +$42.6M 0.22% 127
2018
Q2
$156M Buy
+2,400,219
New +$155M 0.19% 145

Other funds holding CDK

Boston Partners's CDK Position: Q4 2021 in Review

Boston Partners sold out of CDK Global, Inc. (CDK) in Q4 2021, closing a stake of 187,918 shares — an estimated $8M sold.

Boston Partners first reported a position in CDK in Q2 2018 and held it in 14 quarters. The position peaked at $280M in Q4 2019. 448 funds tracked by Wall St. Rank hold CDK as of Q4 2021.

  • Boston Partners reported no remaining CDK Global, Inc. position as of Q4 2021 after selling out during the quarter.
  • Boston Partners sold 187,918 CDK Global, Inc. shares in Q4 2021, an estimated $8M.
  • Boston Partners first reported a position in CDK Global, Inc. in Q2 2018 and held it in 14 quarters.
  • Boston Partners's CDK Global, Inc. position peaked at $280M in Q4 2019.
  • 448 funds tracked by Wall St. Rank held CDK Global, Inc. as of Q4 2021.

Based on Boston Partners's 13F filing for Q4 2021, filed 4 Feb 2022.